تجاوز إلى المحتوى الرئيسي

بحث

عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
Cholecalciferol supplementation in critically ill patients with severe vitamin D deficiency in intensive care unit – a randomized controlled trial King Abdullah Medical City, Makkah Ongoing VITAMIN D3 (CHOLECALCIFEROL) 3 IRB#16-252, V2 King Abdullah Medical City (Makkah)
A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy, Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients with Low Tumor Burden Follicular Lymphoma Archigen Biotech Limited Ongoing Rituximab/ SAIT101 3 AGB 002 Prince Sultan Military Medical City (Riyadh), King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
A Phase 4, Double-Blind, Randomised, Placebo-Controlled Multicenter Study to Assess the Safety and Efficacy of Adalimumab Used in Conjunction with Surgery in Subjects with Moderate to Severe Hidradenitis Suppurativa AbbVie Ongoing Adalimumab 4 M15-574 King Faisal Specialist Hospital and Research Center (Riyadh)
"A PHASE 2/3, MULTICENTER, MULTINATIONAL,OPEN-LABEL STUDY TO EVALUATE THE EFFICACY ANDSAFETY OF ALXN1101 IN NEONATES WITH MOLYBDENUMCOFACTOR DEFICIENCY (MOCD) TYPE A" Alexion Ongoing ALXN1101( Cyclic pyranopterin monophosphate monohydrobromide dihydrate) 2b ALXN1101-MCD-202 King Fahad Medical City (Riyadh)
Post-Authorization Safety Reporting Program of Canagliflozin-based Therapy in Patients With Type 2 Diabetes in Saudi Arabia Janssen-Cilag International NV Ongoing canagliflozin 4 28431754DI Specialized Medical Center (Riyadh), Dr. Soliman Fakeeh Hospital (Jeddah), International Medical Center (Jeddah), Dallah Hospital (Riyadh), Almana Hospital (Jubail), Almouasa Hospital (Qatif), Dr. Sulaiman Al-Habib Medical Group Olaya (Riyadh), Dr. Sulaiman Al-Habib Medical Group Rayan (Riyadh), Saudi German Hospital (Jeddah)
AfME Registry on GastroIntestinal Stromal Tumors (GIST) – A Retrospective Patients’ Profile Description and Evaluation of the Use of Tyrosine Kinase Inhibitors Africa Middle East Cancer Intergroup (AMCI) Ongoing - 4 WI210066 King Fahad Medical City (Riyadh)
Clinical Effectiveness and Cost Implications of Patients Switching from Oral Antipsychotics to Long‑Acting Injectable Antipsychotics in the Treatment of Schizophrenia Janssen-Cilag International NV Ongoing Consta 4 RRA-19315 Alamal Complex for mental health (Riyadh), King Fahad University Hospital (Al-Khobar)
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial Sunnybrook Health Sience Center / KAIMRC Ongoing All SFDA already registered Antibiotics 4 CT 15/022 King Abdulaziz Medical City NG (Riyadh)
The Impact of Tigecycline Use on Fibrinogen Level in Post Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Patients. A Randomized Controlled Study King Faisal Specialist Hospital & Research Center Ongoing Tigecycline 4 RAC#216103 King Faisal Specialist Hospital and Research Center (Riyadh)
Forxiga (dapagliflozin) Post Authorization Safety Study AstraZeneca Ongoing Forxiga 4 D1690R0003 King Khalid University Hospital (Riyadh), Taibah University College of Medicine, Dr. Sulaiman Al-Habib Medical Group (Riyadh), Specialized Medical Center (Riyadh), International Medical Center (Jeddah), Dallah Hospital (Riyadh), King Abdulaziz University Hospital (Jeddah)
عرض 321 - 330 من 514